I Hate Dialysis Message Board
Dialysis Discussion => Dialysis: News Articles => Topic started by: RightSide on November 14, 2008, 09:19:14 AM
-
PRESS RELEASE
Xcorporeal, Inc. Announces the XCR-6 Dialysis Platform for Self-Directed Kidney Hemodialysis
New Machine Makes Home-Based Dialysis a Reality for Millions of Patients Worldwide
Last update: 8:30 a.m. EST Nov. 12, 2008
LOS ANGELES, Nov 12, 2008 (BUSINESS WIRE) -- Xcorporeal, Inc. announced today the XCR-6 Dialysis Platform for self-directed kidney hemodialysis. The XCR-6 will be the smallest, lightest, and easiest to use dialysis machine ever conceived, using Xcorporeal's proprietary closed loop, regenerated dialysate technology platform. The Company is currently preparing for unattended/home use clinical trials of the XCR-6 in anticipation of commercialization in the near future.
The XCR-6 was developed through extensive research and represents a significant improvement compared with equipment currently utilized by patients suffering from chronic renal failure. The technology will, for the first time, allow dialysis providers to "bring the therapy to the patient" because the XCR-6 uses an extremely small amount of tap water; requires no special plumbing or water processing plants; runs on standard household electricity; is the size and weight of a small household appliance; is easy to learn and use as all tubing is integrated into a single proprietary cassette that snaps into place with one hand and retains all fluids within the disposable cassette, facilitating clean up. The Company estimates that the home hemodialysis market represents a multi-billion dollar revenue opportunity.
"We are extremely excited to announce the XCR-6," said Kelly McCrann, Chairman and Chief Executive Officer of Xcorporeal. "The XCR-6 represents the culmination of years of research and development activities in an attempt to change the lives of patients living with kidney dialysis on a daily basis. With its compact size, allowing it to fit into an airline carry-on compartment, the days of patients requiring Center visits for dialysis are numbered. Our ability to deliver a simple, robust, portable, cost-effective solution will finally remove the barriers to home-based hemodialysis services."
Unlike conventional, single pass dialysis machines that require 50 liters or more of dialysate generated by a large water purification plant, Xcorporeal's unique approach requires only 6 liters of dialysate, generated from readily available tap water, and then recirculated in a closed loop to attain the same toxin clearance rates as conventional single pass machines.
http://tinyurl.com/5snuef
-
Just more hype from the company to gain investor's $$.
Will believe it when the FDA approves it.
8)
-
Here is a picture of the prototype.
http://www.syncronessdesign.com/case2.html